Search clinical trials for: epithelial

Total 21950 results

National Cancer Institute (NCI)

Completed

Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis

Stomach Neoplasms | Peritoneal Neoplasms

United States
National Cancer Institute (NCI)

Completed

New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

Neuroblastoma | Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Institute of Diabetes and Digestive and...

Completed

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

Neoplasm Metastasis | Zollinger Ellison Syndrome | Islet Cell Adenoma

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

Lymphoma | Carcinoma, Renal Cell | Cancer | Breast Cancer | Ovarian Cancer

United States
National Institutes of Health Clinical Center (CC)

Completed

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

United States
National Institute of Neurological Disorders and...

Completed

Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor

Glioma | Glioblastoma | Astrocytoma

United States
National Cancer Institute (NCI)

Completed

SU5416 and Carboplatin to Treat Ovarian Cancer

Ovarian Cancer | Peritoneal Neoplasm | Fallopian Tube Neoplasm

United States
National Human Genome Research Institute (NHGRI)

Completed

Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

Carcinoma, Transitional Cell | Bladder Neoplasms

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

Brain Neoplasms | Neuroblastoma

United States
National Cancer Institute (NCI)

Completed

Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

Carcinoma | Peritoneal Neoplasm

United States
National Cancer Institute (NCI)

Completed

Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR

Leukoplakia | Periodontal Disease

United States
National Institute on Deafness and Other Communication...

Completed

The Effects of Upper Airway and Digestive Tract Tumors on the Immune System

Papilloma | Esophageal Neoplasm | Squamous Cell Carcinoma | Head and Neck Neoplasm | Laryngeal Neoplasm

United States
National Cancer Institute (NCI)

Completed

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Psoriasis | Basal Cell Carcinoma | Keratosis Palmaris et Plantaris

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Melanoma | Lymphoma | Renal Cell Carcinoma | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

Breast Neoplasm | Hereditary Neoplastic Syndrome

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

Prostatic Neoplasms

United States
National Institute of Neurological Disorders and...

Completed

The Role of Gene Changes in Brain Tumor Formation and Growth

Glioma

United States
National Institute of Diabetes and Digestive and...

Completed

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)

Insulinoma

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer

Squamous Cell Carcinoma | Head and Neck Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors

Glioma | Brain Neoplasms | Medulloblastoma

United States
Ulsan University Hospital
Jeil Pharmaceutical Co., Ltd.

Unknown

Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma

Carcinoma, Non-Small-Cell Lung

Korea, Republic of
Millennium Pharmaceuticals, Inc.

Completed

Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

Colorectal Carcinoma

United States
Sanofi

Completed

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

France
Medical University of Vienna

Completed

Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy (atropinePEI)

Arrhythmia | Respiratory Arrest

Austria
University of Milan

Completed

Alternative Surgical Policy for Central Liver Tumors

Hepatocellular Carcinoma | Colorectal Liver Metastases

Italy
SciClone Pharmaceuticals

Completed

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
University of Michigan Rogel Cancer Center
Eli Lilly and Company

Terminated

Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

Carcinoma of Unknown Primary

United States
Aptose Biosciences Inc.
University of Chicago; Wake Forest University

Completed

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

Carcinoma, Renal Cell | Metastases, Neoplasm

United States
Astellas Pharma Inc

Completed

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Lung Cancer | Carcinoma, Non-Small Cell Lung | Cancer of Lung | Non-Small Cell Lung Carcinoma | Cancer of the Lung

Germany, Czech Republic, Netherlands
Emory University
Novartis

Terminated

Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma

Gastric Adenocarcinoma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

Squamous Cell Carcinoma

United States
Callisto Pharmaceuticals

Completed

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

United States
AstraZeneca

Completed

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Head and Neck Cancer

Hong Kong, Singapore
Unither Pharmaceuticals

Terminated

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Ovarian Cancer
AstraZeneca

Completed

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Colorectal Cancer

Spain
Unither Pharmaceuticals

Terminated

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Ovarian Neoplasms

Canada, United States
Unither Pharmaceuticals

Terminated

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Ovarian Neoplasms

United States
Unither Pharmaceuticals

Terminated

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer

United States
Aga Khan University

Completed

Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC) (HCC-CAP)

Carcinoma, Hepatocellular

Pakistan
NHS Tayside

Completed

A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma

Carcinoma, Basal Cell

United Kingdom
Donnenfeld, Eric, M.D.

Completed

Effect of Topical Fluoroquinolones on Epithelial Wound Healing After PRK

Corneal Epithelial Wound Healing
Light Sciences Oncology

Completed

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Liver Neoplasms

Taiwan, Hong Kong, Singapore
Attenuon

Terminated

ATN-161 in Advanced Renal Cell Cancer

Carcinoma, Renal Cell

United States
Abbott

Completed

A Long Term Safety Study With Atrasentan

Adenocarcinoma | Prostate Cancer

Canada, United States, France, Netherlands, United Kingdom
Abbott

Completed

A Study of ABT-751 in Patients With Renal Cell Cancer

Renal Cell Cancer

Canada, United States
Oncoscience AG
Heinrich-Heine University, Duesseldorf; University of Cologne; Universitätsklinikum... and other collaborators

Completed

Nimotuzumab in Children With HGG

High Grade Glioma

Germany
Ministry of Scientific Research and Information...

Terminated

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Esophageal Neoplasms | Squamous Cell Cancer

Poland
Associacio catalana per a la recerca oncologica...
Hoffmann-La Roche

Unknown

XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Rectal Neoplasms | Locally Advanced Rectal Adenocarcinoma

Spain

Search clinical trials for: epithelial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations